PanCAN’s Julie Fleshman’s letter urges Congress to reject cuts to NIH

George Weiner: Cancer centers are special, as are site visits in CCSG review

The cancer center program of the NCI is a success that is admired not only within the NIH but worldwide. This is due, in large part, to the cancer center review process that has evolved and strengthened over the years.

Cyber-iconoclast Vinay Prasad named head of FDA’s CBER
An oncologist, Prasad has criticized accelerated approval, next-gen sequencing, and targeted therapies

Vinay Prasad, a MAHA-aligned hematologist-oncologist with an avid cyber following, was named director of the FDA Center for Biologics Evaluation and Research, where he will be responsible for the agency’s regulation of vaccines and biologics, including cell and gene therapies.

May 09, 2025

Vol.51 No.18

By Claire Marie Porter

Cancer Policy

Bhattacharya cancels NIH all-hands meeting

In an interview with Science, NIH Director Jay Bhattacharya said that his time at the NIH has been a “tough period”—especially for him.

NIH to update policies and practices, halting subawards to foreign entities

In a statement issued on May 1, NIH said it’s immediately halting most new grant awards to foreign partners working in US-led research consortia.

May 09, 2025

Vol.51 No.18

By Claire Marie Porter

Cancer Policy

AACR calls on Congress to reject Trump’s FY2026 budget request for NIH

The American Association for Cancer Research called on Congress to stand up in unified opposition to President Trump’s FY2026 budget proposal for NIH, and to instead allocate a robust funding increase to $51.3 billion for the NIH (The Cancer Letter, May 2, 2025).

Incidence rates of some cancer types have risen in people under age 50, NCI study shows

Researchers at NCI have completed a comprehensive analysis of cancer statistics for different age groups in the United States and found that from 2010 through 2019, the incidence of 14 cancer types increased among people under age 50.

May 09, 2025

Vol.51 No.18

PanCAN’s Julie Fleshman’s letter urges Congress to reject cuts to NIH

YOU MAY BE INTERESTED IN

George Weiner: Cancer centers are special, as are site visits in CCSG review

Cyber-iconoclast Vinay Prasad named head of FDA’s CBER
An oncologist, Prasad has criticized accelerated approval, next-gen sequencing, and targeted therapies

Bhattacharya cancels NIH all-hands meeting

NIH to update policies and practices, halting subawards to foreign entities

AACR calls on Congress to reject Trump’s FY2026 budget request for NIH

Incidence rates of some cancer types have risen in people under age 50, NCI study shows

Renew today!

Subscriber content

Never miss an issue!

Login

PanCAN’s Julie Fleshman’s letter urges Congress to reject cuts to NIH

YOU MAY BE INTERESTED IN

George Weiner: Cancer centers are special, as are site visits in CCSG review

Cyber-iconoclast Vinay Prasad named head of FDA’s CBERAn oncologist, Prasad has criticized accelerated approval, next-gen sequencing, and targeted therapies

Bhattacharya cancels NIH all-hands meeting

NIH to update policies and practices, halting subawards to foreign entities

AACR calls on Congress to reject Trump’s FY2026 budget request for NIH

Incidence rates of some cancer types have risen in people under age 50, NCI study shows

Never miss an issue!

Login

Cyber-iconoclast Vinay Prasad named head of FDA’s CBER
An oncologist, Prasad has criticized accelerated approval, next-gen sequencing, and targeted therapies